Answers are grounded in this paper and cite their sources.
Type-1 glycan unit, Galβ1-3GlcNAc, is one of the two major backbones from which the large glycan determinant repertoire is derived. Numerous type-1 glycan determinants, including Lewis-series antigens, have been identified, often featuring fucosylation and sialylation. In this study, we achieved efficient synthesis of 30 type-1 determinants using a divergent enzymatic strategy. The synthetic efficiency of eight fucosyltransferases (FucTs) was evaluated for the installation of fucose at every step of the type-1 determinant synthesis. Using selected FucTs and a few additional robust glycosyltransferases, 22 basic type-1 determinants were constructed at preparative scales in no more than three steps, starting from the type-1 unit. Additionally, 8 extended type-1 Lewis antigens were successfully synthesized in no more than five steps. Subsequent glycan microarray assays of these glycan determinants revealed intriguing recognitions by glycan-binding proteins and anti-type-1 Lewis antigen monoclonal antibodies.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: